Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
Aminophylline (250mg IV +/- a second dose of 250mg IV)The purpose of this study is to evaluate the effect of aminophylline in patients with out-of-hospital bradyasystolic cardiac arrest. SEP Phase 2 À vérifier Canada À vérifier
Aminophylline (250mg IV +/- a second dose of 250mg IV)The purpose of this study is to evaluate the effect of aminophylline in patients with out-of-hospital bradyasystolic cardiac arrest. SEP Phase 2 À vérifier Canada À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
Aminophylline (250mg IV +/- a second dose of 250mg IV) SEP Phase 2 NCT00312273 Aminophylline in Bradyasystolic Cardiac Arrest COMPLETED

Publications

0
MoléculeIndication / populationTitreJournalDate
Aucune publication.